Therapeutic Options for Hydrating Airway Mucus in Cystic Fibrosis

Publisher： Karger

E-ISSN： 1423-0313|95|3-4|117-132

ISSN： 0031-7012

Source： Pharmacology, Vol.95, Iss.3-4, 2015-03, pp. : 117-132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of IRE1α/XBP-1 in Cystic Fibrosis Airway Inflammation

By Ribeiro Carla M. P.   Lubamba Bob A.  

International Journal of Molecular Sciences, Vol. 18, Iss. 1, 2017-01 ,pp. : 118-118

MDPI

Access to resources Recommend Favorite

Respiratory Syncytial Virus Infection Disrupts Monolayer Integrity and Function in Cystic Fibrosis Airway Cells

By Michele Kong   Patrick Maeng   Jeong Hong   Rhonda Szczesniak   Eric Sorscher   Wayne Sullender   John Paul Clancy  

Viruses, Vol. 5, Iss. 9, 2013-09 ,pp. : 2260-2271

MDPI

Access to resources Recommend Favorite

High-Dose Ibuprofen in Cystic Fibrosis

By Lands Larry C.   Dauletbaev Nurlan  

Pharmaceuticals, Vol. 3, Iss. 7, 2010-07 ,pp. : 2213-2224

MDPI

Access to resources Recommend Favorite

Novel Therapies to Inhibit Mucus Synthesis and Secretion in Airway Hypersecretory Diseases

By  

Pharmacology, Vol. 97, Iss. 1-2, 2016-0 ,pp. : 84-100

Karger

Access to resources Recommend Favorite

Oxytetracycline Inhibits Mucus Secretion and Inflammation in Human Airway Epithelial Cells

By  

Chemotherapy, Vol. 62, Iss. 5, 2017-06 ,pp. : 301-306

Karger

Access to resources Recommend Favorite